CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
about
Concerning RNA-guided gene drives for the alteration of wild populationsFlowing through the CRISPR-CAScade: Will genome editing boost cell therapies?Plant genome editing made easy: targeted mutagenesis in model and crop plants using the CRISPR/Cas systemCRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systemsCRISPR/Cas9-mediated gene editing in human tripronuclear zygotesProgrammable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domainCas9 as a versatile tool for engineering biologyNewer gene editing technologies toward HIV gene therapyMulti-OMICs and Genome Editing Perspectives on Liver Cancer Signaling NetworksGenome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biologyRecent Advances in Genome Editing Using CRISPR/Cas9The CRISPR/Cas Genome-Editing Tool: Application in Improvement of CropsGenome Engineering with TALE and CRISPR Systems in NeuroscienceBrain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureRNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?The Rise of CRISPR/Cas for Genome Editing in Stem CellsCRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic VirusesGenome-editing Technologies for Gene and Cell TherapyCRISPR/Cas9 and cancer targets: future possibilities and present challengesNuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome EditingTowards a new era in medicine: therapeutic genome editingInduced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesBeyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogationApplications of CRISPR-Cas systems in neuroscienceHow specific is CRISPR/Cas9 really?Origins of Programmable Nucleases for Genome EngineeringMinimizing off-Target Mutagenesis Risks Caused by Programmable NucleasesApplication of CRISPR/Cas9 Technology to HBVA new age in functional genomics using CRISPR/Cas9 in arrayed library screeningApplications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology ResearchEnabling functional genomics with genome engineeringStrategies for precision modulation of gene expression by epigenome editing: an overviewCurrent and future prospects for CRISPR-based tools in bacteriaThe application of CRISPR-Cas9 genome editing in Caenorhabditis elegansThe New State of the Art: Cas9 for Gene Activation and RepressionDesigned nucleases for targeted genome editingCRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseasesTranscription activator-like effectors: a toolkit for synthetic biologyClassification and evolution of type II CRISPR-Cas systemsOff-target Effects in CRISPR/Cas9-mediated Genome Engineering
P2860
Q21128771-E401BADB-493C-4F79-BDE8-1B6FCC25FEE7Q21195748-50464B7E-62B1-4CD1-8F0C-B76896E2BC2DQ21203587-1FB3ED28-104F-4C04-9B0C-774580514DCDQ21558788-45BAD738-4DCA-4D7E-9709-3D5F640FDFB8Q22337358-578C177D-A3B3-4359-BD79-6D6A9E98B2BCQ24563826-7FCF8AB2-0763-4B47-955D-DAC3862BE7EFQ24564294-465A083C-BE4F-4DDE-BE68-4BC08828F305Q24631042-C46E82C7-8928-48F8-8314-50628322E842Q26741086-4CDC4262-48B7-4C0F-966D-BD30C82E35B6Q26742051-FA509E54-3317-420E-8AF5-53C62B5F65B2Q26744073-EDFA58DF-C7B7-470F-AC90-7FADC5F189F8Q26752469-2A4ED646-D85E-4AA6-BC15-161237AC8EEEQ26752488-03925359-C7E2-4202-A694-54D8656DFDCFQ26753206-C347E690-BB4E-4641-AB46-96D27E62F539Q26765460-BF6F0462-DEF8-400A-8072-F6281BAB6119Q26765852-A4792903-7069-447F-8F2B-3E2CE0D47833Q26766798-57172B9C-8BE2-4F03-A52A-F4FC02F66AB4Q26769662-9A0D4057-EECD-4D5D-8FE7-6A8B255E0D04Q26769907-E4DE1730-1C88-45D5-B73A-250FCE959DF2Q26770012-76AC7D09-4A44-4EDC-B82B-E306527AD670Q26773287-69B716FC-F105-4835-8BFB-8FCEF3710528Q26775061-60800506-3454-47A0-8899-50AAE285AD98Q26775746-C9DCAA93-6213-45CF-A404-F9EDF168A441Q26776515-4FAE0050-EF5E-4324-991D-BBBF08312673Q26777801-6EDBD40B-5489-44BF-9BE8-8A90E7310CB0Q26778501-F7931FCB-29DB-4F6F-A43F-74DB123B0CA5Q26778992-C4F34CFC-A748-4C1B-9BEC-C3939A548EFEQ26779150-5B20BEBF-57D7-4C65-9C06-CAD65A59DF4AQ26781135-37C456FA-DF90-4991-A7E2-1D812D8DA66AQ26781399-2E4293FD-B08A-458A-8C60-0F88AF456D53Q26782747-F2295734-7C65-448B-892C-C9B743FFF71AQ26782876-FA00B862-A54C-407B-8FF5-A08F11172034Q26783837-10E04B78-274D-4583-AFAE-68A2E81999C1Q26785937-AE9FBF5A-9728-4BB1-9D1C-B20F28740CC8Q26787037-D46C2B8E-8E98-4A50-8E34-474631072E84Q26787105-7ABDA684-F13A-4DD6-B53B-131A8BAE99D6Q26799640-8BA943EE-873E-498B-AC62-0B79374F095BQ26829980-0694D4C8-3C87-4F14-8F9B-EB99D5C79563Q26850610-D26CF7A9-C6BB-4764-B46D-40EEDF321C8BQ26859390-C6EB3FB7-F9A8-4038-922C-3826718D7FBF
P2860
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
CAS9 transcriptional activator ...... cooperative genome engineering
@ast
CAS9 transcriptional activator ...... cooperative genome engineering
@en
type
label
CAS9 transcriptional activator ...... cooperative genome engineering
@ast
CAS9 transcriptional activator ...... cooperative genome engineering
@en
prefLabel
CAS9 transcriptional activator ...... cooperative genome engineering
@ast
CAS9 transcriptional activator ...... cooperative genome engineering
@en
P2093
P2860
P3181
P356
P1433
P1476
CAS9 transcriptional activator ...... cooperative genome engineering
@en
P2093
Moosburner M
Stranges PB
P2860
P2888
P3181
P356
10.1038/NBT.2675
P407
P577
2013-09-01T00:00:00Z
P5875
P6179
1041659759